This might be a consequence of the IgM and IgA enriched immunoglobulin G treatment that helps and supports the resolution of complications due to a secondary bacterial sepsis in relation to their adjuvant support to the sepsis-related phases and the microcirculation, impaired in the severe stage of infection [13,14,15]. The gene discussed is CD40LG; the disease is bacterial infectious disease with sepsis.